Arcutis Biotherapeutics ARQT
$26.36 −$0.81 (-2.98%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $26.40 +0.15%
Open$26.91
Prev close$27.17
Day range$26.29 – $27.47
Volume1.29M
Market cap$3.33B
P/E (TTM)119.8
Dividend yield–
Analyst view
ConsensusBuy
Analysts5
Average target$42.00+59.3% vs. price
- Buy 100%
Low $38.00Now $26.36Avg $42.00High $48.00
Recent rating changes
The last 20 actions on file set price targets from $34.00 to $48.00, averaging $37.15.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 5 Nov 2026 | Morgan Stanley | BUY | $38.00 |
| 5 Nov 2026 | H.C. Wainwright | BUY | $40.00 |
| 4 Nov 2026 | TD Cowen | BUY | $40.00 |
| 19 Oct 2026 | Guggenheim | BUY | $44.00 |
| 15 Oct 2026 | Cantor Fitzgerald | BUY | $48.00 |
| 10 Aug 2026 | H.C. Wainwright | BUY | $34.00 |
| 6 Aug 2026 | Morgan Stanley | BUY | $38.00 |
| 6 Aug 2026 | Needham | BUY | $40.00 |
| 6 Aug 2026 | H.C. Wainwright | BUY | $34.00 |
| 5 Aug 2026 | TD Cowen | BUY | $35.00 |
| 5 Aug 2026 | Guggenheim | BUY | $38.00 |
| 16 Jul 2026 | Guggenheim | BUY | $35.00 |
| 30 Jun 2026 | Needham | BUY | $36.00 |
| 11 May 2026 | H.C. Wainwright | BUY | $34.00 |
| 7 May 2026 | TD Cowen | BUY | $35.00 |
| 7 May 2026 | Morgan Stanley | BUY | $34.00 |
| 7 May 2026 | Needham | BUY | $36.00 |
| 7 May 2026 | H.C. Wainwright | BUY | $34.00 |
| 23 Apr 2026 | TD Cowen | BUY | $35.00 |
| 22 Apr 2026 | Morgan Stanley | BUY | $35.00 |
No comments yet — be the first to weigh in on ARQT.
Sign in to join the discussion.